This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research, where it serves as a key intermediate in the synthesis of targeted cancer therapies. Its structure is particularly valuable in the development of tyrosine kinase inhibitors, which are used to treat various types of cancers by blocking specific enzymes that promote tumor growth. Researchers focus on its potential to inhibit epidermal growth factor receptor (EGFR) pathways, making it a candidate for treating cancers such as non-small cell lung cancer, breast cancer, and colorectal cancer. Additionally, its modified quinazoline core is explored for optimizing drug efficacy and selectivity in preclinical studies.